Therefore, MK via inhibition of CysLT1R can reduce the severity of myocardial ischemia by inhibiting apoptosis and the production of reactive oxygen species (ROS) (Figure 3) [74]. The gene discussed is CYSLTR1; the disease is myocardial ischemia.